We are live on ! Find out more
SS

SBI Securities Portfolio holdings

AUM $4.4B
1-Year Est. Return 74.26%
This Fund
S&P 500
This Quarter Est. Return
+15.36%
1 Year Est. Return
+74.26%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.9B
AUM Growth
+$429M
Cap. Flow
-$34.1M
Cap. Flow %
-0.87%
Top 10 Hldgs %
43.62%
Holding
4,347
New
202
Increased
1,425
Reduced
1,653
Closed
154

Top Buys

Rank Stock Value
1
KYIV
Kyivstar Group
KYIV
+$13.8M
2
CRWV
CoreWeave
CRWV
+$9.67M
3
TSLA icon
Tesla
TSLA
+$8.76M
4
GLDM icon
SPDR Gold MiniShares Trust
GLDM
+$7.91M
5
NVDA icon
NVIDIA
NVDA
+$6.89M

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.89%
2 Technology 29.37%
3 Communication Services 7.63%
4 Consumer Discretionary 7.28%
5 Financials 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIC
3176
TIC Solutions Inc
TIC
$2.09B
$306 ﹤0.01%
+23
New +$262
EVC icon
3177
Entravision Communication
EVC
$745M
$305 ﹤0.01%
131
-12
-8% -$29
NRIX icon
3178
Nurix Therapeutics
NRIX
$2.72B
$305 ﹤0.01%
33
+15
+83% +$156
RICK icon
3179
RCI Hospitality Holdings
RICK
$231M
$305 ﹤0.01%
10
SDVY icon
3180
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.6B
$304 ﹤0.01%
8
-1
-11% -$37
TNDM icon
3181
Tandem Diabetes Care
TNDM
$1.49B
$304 ﹤0.01%
25
+7
+39% +$95
WS icon
3182
Worthington Steel
WS
$1.74B
$304 ﹤0.01%
10
ONT
3183
Onterris Inc
ONT
$598M
$302 ﹤0.01%
11
TRT
3184
Trio-Tech International
TRT
$102M
$302 ﹤0.01%
102
ABTS icon
3185
Abits Group
ABTS
$4.4M
$301 ﹤0.01%
33
TKR icon
3186
Timken Company
TKR
$8.37B
$301 ﹤0.01%
4
+1
+33% +$77
GRCE
3187
Grace Therapeutics
GRCE
$44.6M
$301 ﹤0.01%
101
TRAW icon
3188
Traws Pharma
TRAW
$9.07M
$300 ﹤0.01%
162
BCPC
3189
Balchem Corp
BCPC
$5.69B
$300 ﹤0.01%
2
CRDF icon
3190
Cardiff Oncology
CRDF
$73.1M
$299 ﹤0.01%
145
-819
-85% -$2.26K
ENR icon
3191
Energizer
ENR
$1.53B
$299 ﹤0.01%
12
-4
-25% -$105
GEF icon
3192
Greif
GEF
$4.78B
$299 ﹤0.01%
5
+2
+67% +$129
GLSI icon
3193
Greenwich LifeSciences
GLSI
$230M
$299 ﹤0.01%
30
RBLU
3194
T-REX 2X Long RBLX Daily Target ETF
RBLU
$9.46M
$298 ﹤0.01%
3
-25
-89% -$2.11K
GROW icon
3195
US Global Investors
GROW
$41.3M
$297 ﹤0.01%
108
-2
-2% -$5
PBYI icon
3196
Puma Biotechnology
PBYI
$468M
$297 ﹤0.01%
56
BFRI icon
3197
Biofrontera
BFRI
$23.6M
$296 ﹤0.01%
301
-1
-0.3% -$1
CPSH icon
3198
CPS Technologies
CPSH
$73.7M
$296 ﹤0.01%
83
+40
+93% +$124
PXLW icon
3199
Pixelworks
PXLW
$41.9M
$296 ﹤0.01%
27
-1
-4% -$10
AVTX icon
3200
Avalo Therapeutics
AVTX
$1.05B
$292 ﹤0.01%
23
+1
+5% +$9

Similar funds

SBI Securities's Q3 2025 Portfolio in Review

As of Q3 2025, SBI Securities held 4,347 positions worth $3.9B, up 12% from $3.48B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

SBI Securities's Q3 2025 filing shows 202 new, 1,425 increased, 1,653 reduced and 154 closed positions. Its largest new stake was Kyivstar Group: 1,158,993 shares worth $14.5M. The largest sale was Berkshire Hathaway Class B, an estimated $35.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, down from 44% a quarter earlier, followed by Technology and Communication Services.

  • SBI Securities's largest Q3 2025 buy was Kyivstar Group: 1,158,993 shares worth $14.5M.
  • SBI Securities added most to CoreWeave in Q3 2025, an estimated $9.67M increase.
  • SBI Securities's biggest Q3 2025 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $12.7M.
  • SBI Securities fully exited Berkshire Hathaway Class B in Q3 2025, selling an estimated $35.4M.
  • SBI Securities's ten largest holdings make up 44% of its $3.9B portfolio in Q3 2025.
  • SBI Securities opened 202 new positions and closed 154 in Q3 2025.
  • SBI Securities's portfolio value rose 12% quarter-over-quarter to $3.9B.

Based on SBI Securities's 13F filing for Q3 2025, filed 5 Nov 2025.